Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2022-04-01
Edice:Thrombosis Journal
Témata:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
On-line přístup:https://doi.org/10.1186/s12959-022-00380-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky